Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide

We provide evidence that arsenic trioxide (As(2)O(3)) targets the BCR-ABL oncoprotein via a novel mechanism involving p62/SQSTM1-mediated localization of the oncoprotein to the autolysosomes and subsequent degradation mediated by the protease cathepsin B. Our studies demonstrate that inhibitors of a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Goussetis, Dennis J., Gounaris, Elias, Wu, Edward J., Vakana, Eliza, Sharma, Bhumika, Bogyo, Matthew, Altman, Jessica K., Platanias, Leonidas C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2012
Soggetti:
Myeloid Neoplasia
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3482863/
https://ncbi.nlm.nih.gov/pubmed/22898604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-01-402578
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi